Significant Accounting Policies - Additional Information (Detail) - USD ($) |
3 Months Ended | ||
|---|---|---|---|
Apr. 30, 2015 |
Mar. 31, 2021 |
Mar. 31, 2020 |
|
| Summary Of Significant Accounting Policies [Line Items] | |||
| Revenue | $ 145,065 | $ 61,475 | |
| Research and development expense, total | 4,591,244 | 4,575,303 | |
| Liability for unrecognized tax benefits | 0 | ||
| Interest or penalties for uncertain tax positions | $ 0 | $ 0 | |
| Antidilutive securities excluded from computation of earnings per share, amount | 7,137,741 | 7,206,004 | |
| Employee Stock Purchase Plan [Member] | |||
| Summary Of Significant Accounting Policies [Line Items] | |||
| Common stock purchase price discount percentage | 85.00% | 15.00% | |
| Product Development Projects Revenue [Member] | |||
| Summary Of Significant Accounting Policies [Line Items] | |||
| Revenue | $ 145,065 | $ 20,850 | |
| Royalty Revenue [Member] | |||
| Summary Of Significant Accounting Policies [Line Items] | |||
| Revenue | 0 | 0 | |
| Contract Services Revenue [Member] | |||
| Summary Of Significant Accounting Policies [Line Items] | |||
| Revenue | $ 0 | $ 40,625 | |
| X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Discount rate from fair value on purchase date that participants pay for shares. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of unrecognized tax benefits. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|